Trial Profile
Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 25 May 2017 New trial record